SVF Endurance (Cayman) Ltd
SEC CIK 1782338 · EDGAR
BoughtSold
Most active insiders at VIR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | SVF Endurance (Cayman) Ltd | 10% | — | $9.38M |
| 2 | SB INVESTMENT ADVISERS (UK) LTD | 10% | — | $5.72M |
| 3 | SOFTBANK VISION FUND (AIV M1) L.P. | 10% | — | $2.76M |
| 4 | SATO VICKI L | Dir | — | $1.73M |
| 5 | De Backer Marianne | Pres, CEO, Dir | — | $946.9K |
| 6 | de Verneuil Vanina | EVP, GC, Corp Sec | — | $217.7K |
| 7 | Sabatini Brent | SVP, CAO | — | $113.1K |
| 8 | O'Byrne Jason | EVP, CFO | — | $68.9K |
| 9 | Eisner Mark | EVP, Chief Medical Off | — | $49.5K |
| 10 | Napolitano Janet | Dir | — | $30.2K |
Transactions 23
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-12-03 | 2025-12-01 | VIR | Vir Biotechnology, Inc. | SVF Endurance (Cayman) Ltd | 10% | S - Sale | $5.98 | -191.9K | 13.73M | -1% | -$1.15M |
| MI | 2025-11-26 | 2025-11-24+ | VIR | Vir Biotechnology, Inc. | SVF Endurance (Cayman) Ltd | 10% | S - Sale | $6.27 | -463.8K | 14.11M | -3% | -$2.91M |
| MI | 2025-10-30 | 2025-10-28+ | VIR | Vir Biotechnology, Inc. | SVF Endurance (Cayman) Ltd | 10% | S - Sale | $6.50 | -24.6K | 14.57M | -0.2% | -$159.6K |
| MI | 2025-10-22 | 2025-10-20+ | VIR | Vir Biotechnology, Inc. | SVF Endurance (Cayman) Ltd | 10% | S - Sale | $6.23 | -330.2K | 15.01M | -2% | -$2.06M |
| MI | 2025-10-17 | 2025-10-15+ | VIR | Vir Biotechnology, Inc. | SVF Endurance (Cayman) Ltd | 10% | S - Sale | $6.08 | -29.5K | 15.34M | -0.2% | -$179.5K |
| MI | 2025-10-07 | 2025-10-03+ | VIR | Vir Biotechnology, Inc. | SVF Endurance (Cayman) Ltd | 10% | S - Sale | $5.58 | -524.3K | 16.23M | -3% | -$2.92M |
| I | 2025-03-26 | 2025-03-24 | COMP | Compass, Inc. | SVF Endurance (Cayman) Ltd | 10% | S - Sale | $9.15 | -10.00M | 48.07M | -17% | -$91.50M |
| I | 2023-06-22 | 2023-06-20 | VIR | Vir Biotechnology, Inc. | SVF Endurance (Cayman) Ltd | 10% | S - Sale | $25.18 | -9,902 | 16.78M | -0.1% | -$249.3K |
| MI | 2023-06-20 | 2023-06-15+ | VIR | Vir Biotechnology, Inc. | SVF Endurance (Cayman) Ltd | 10% | S - Sale | $25.56 | -183.3K | 16.79M | -1% | -$4.69M |
| MI | 2023-06-15 | 2023-06-13+ | VIR | Vir Biotechnology, Inc. | SVF Endurance (Cayman) Ltd | 10% | S - Sale | $26.75 | -164.1K | 17.01M | -1.0% | -$4.39M |
| MI | 2023-05-23 | 2023-05-19+ | VIR | Vir Biotechnology, Inc. | SVF Endurance (Cayman) Ltd | 10% | S - Sale | $25.55 | -183.5K | 17.45M | -1% | -$4.69M |
| I | 2023-05-03 | 2023-05-01 | VIR | Vir Biotechnology, Inc. | SVF Endurance (Cayman) Ltd | 10% | S - Sale | $25.30 | -3,075 | 17.83M | -0.0% | -$77.8K |
| MI | 2023-04-24 | 2023-04-20+ | VIR | Vir Biotechnology, Inc. | SVF Endurance (Cayman) Ltd | 10% | S - Sale | $25.76 | -312.0K | 18.21M | -2% | -$8.04M |
| MI | 2023-04-20 | 2023-04-18+ | VIR | Vir Biotechnology, Inc. | SVF Endurance (Cayman) Ltd | 10% | S - Sale | $25.12 | -83.1K | 18.29M | -0.5% | -$2.09M |
| MI | 2023-02-23 | 2023-02-21 | VIR | Vir Biotechnology, Inc. | SVF Endurance (Cayman) Ltd | 10% | S - Sale | $28.43 | -74.5K | 18.39M | -0.4% | -$2.12M |
| MI | 2023-02-13 | 2023-02-09+ | VIR | Vir Biotechnology, Inc. | SVF Endurance (Cayman) Ltd | 10% | S - Sale | $26.28 | -234.3K | 18.55M | -1% | -$6.16M |
| MI | 2023-02-09 | 2023-02-07+ | VIR | Vir Biotechnology, Inc. | SVF Endurance (Cayman) Ltd | 10% | S - Sale | $28.52 | -145.4K | 18.79M | -0.8% | -$4.15M |
| MI | 2023-02-03 | 2023-02-01+ | VIR | Vir Biotechnology, Inc. | SVF Endurance (Cayman) Ltd | 10% | S - Sale | $29.41 | -148.6K | 19.13M | -0.8% | -$4.37M |
| MI | 2023-01-12 | 2023-01-10+ | VIR | Vir Biotechnology, Inc. | SVF Endurance (Cayman) Ltd | 10% | S - Sale | $26.32 | -149.6K | 20.08M | -0.7% | -$3.94M |
| I | 2023-01-03 | 2022-12-29 | VIR | Vir Biotechnology, Inc. | SVF Endurance (Cayman) Ltd | 10% | S - Sale | $25.55 | -44.2K | 20.26M | -0.2% | -$1.13M |
| I | 2022-12-29 | 2022-12-27 | VIR | Vir Biotechnology, Inc. | SVF Endurance (Cayman) Ltd | 10% | S - Sale | $25.59 | -6,850 | 20.30M | -0.0% | -$175.3K |
| MI | 2022-11-30 | 2022-11-28+ | VIR | Vir Biotechnology, Inc. | SVF Endurance (Cayman) Ltd | 10% | S - Sale | $27.42 | -109.1K | 21.08M | -0.5% | -$2.99M |
| MI | 2022-11-09 | 2022-11-07+ | VIR | Vir Biotechnology, Inc. | SVF Endurance (Cayman) Ltd | 10% | S - Sale | $27.26 | -182.1K | 21.95M | -0.8% | -$4.96M |
Purchase Sale Sale after option exercise All abbreviations